Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04425720 · ClinicalTrials.gov registry record · NA
Use of Remote Monitoring for COVID-19 Patient
A NA study, sponsored by Montefiore Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT04425720 is a NA study that has completed, run by Montefiore Medical Center. The registered enrollment target is 300 participants.
The verdict
NCT04425720, a NA study, has completed, sponsored by Montefiore Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The central hypothesis motivating this study is that remote patient monitoring (RPM) of infectious disease patients can efficiently facilitate self-isolation. Additionally, RPM can assist in more rapid identification of patients at risk, facilitate detection of patient deterioration, and enable early interventions, all of which play a vital role in resource utilization and outcomes.
Interventions
- OTHER Standard of Care
- DEVICE LifeSignals Biosensor 1AX*
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-09-01 |
| Est. Completion | 2021-12-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04425720
The ClinicalTrials.gov registry entry for NCT04425720 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT04425720 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04425720 about?
NCT04425720 is a clinical study titled "Use of Remote Monitoring for COVID-19 Patient". The central hypothesis motivating this study is that remote patient monitoring (RPM) of infectious disease patients can efficiently facilitate self-isolation. Additionally, RPM can assist in more rapid identification of patients at risk, facilitate detection of patient deterioration, and enable earl...
What is the current status of trial NCT04425720?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2020-09-01. Estimated completion is 2021-12-10.
What interventions are being tested in trial NCT04425720?
The interventions under investigation include: Standard of Care (OTHER), LifeSignals Biosensor 1AX* (DEVICE).
Who is sponsoring clinical trial NCT04425720?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.